Biological Information
Family:
Oncology
Organism:
Human
Construct Details:
Endogenous
Cell Type:
PLC/PRF/5
Assay Information
Assay Type:
Functional
Assay Sub Type:
Cell Based
Functional Mode:
Antagonist
Detection Method:
Luminescence
Measured Response:
Luminescence
Testing Information
Procedure Summary:
Human liver hepatoma PLC/PRF/5 cells (ATCC, CRL-8024), (3 x 10^4/ml in growth medium), are pre-incubated in 96-well plates in an atmosphere of 5% CO2 at 37°C overnight. Test compound and/or vehicle is then added for an additional 72 hours. After the 72-hour incubation, CellTiter-Glo reagent is added and for a 10 minute incubation luminescence is measured using a microplate reader. Growth inhibition (GI50), total growth inhibition (TGI) and the 50% lethal concentration (LC50) are reported.
Incubation:
3 d at 37°C
Control Inhibitor:
Staurosporine
Criteria For Significance:
≤ 50% Cell Growth
Test Concentration / Dose:
Compounds are screened at 30, 10, 3, 1, 0.3, 0.1, 0.03 and 0.01 μM
Test Sample Requirements:
75 μl of 10 mM stock or 1 mg (pre-weighed) powder (assuming FW ≦500 and purity 100%)
Minimum Order Quantity:
16
Turnaround Time
Standard:
20 Business Days
Reference Compound Data
Clinical Relevance
Therapeutic Area:
Oncology/Immuno-Oncology
Additional Information
Brand:
Panlabs
Testing Location:
Taiwan - Taipei